ESC 365
ESC 365
Sign in

    Back

    Panel discussion.

    30 August 2021 (15:25 - 15:30)
    Organised by:
    Congress Presentation Part of: Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial. Atrial Fibrillation (AF) Open Access ESC Congress 2021 - The Digital Experience

    3 More presentations in this session

    Presentation thumbnail
    Welcome and introduction.
    Doctor S. Saito (Kamakura, JP)
    Presentation thumbnail
    Edoxaban in patients with AF following TAVI: ENVISAGE-TAVI AF trial results.
    Professor N. van Mieghem (Rotterdam, NL)
    Presentation thumbnail
    New developments in NOACs and TAVI: How do we apply them in clinical practice?
    Professor D. Capodanno (Catania, IT)

    Access the full session

    Session thumbnail
    Anticoagulation in Transcatheter Aortic Valve Implantation in Patients with Atrial Fibrillation: Results from ENVISAGE-TAVI AF trial.
    Video

    The Event

    Event poster

    ESC Congress 2021 - The Digital Experience

    30 August 2021 15:25 CET
    You may be interested in
    thumbnail
    Congress Session
    Treatment strategies for atrial fibrillation in heart failure
    Logo
    thumbnail
    Congress Session
    EHRA Myths - Device-detected atrial fibrillation
    Logo
    thumbnail
    Congress Session
    Stroke prevention in clinical and subclinical atrial fibrillation
    Logo